Issue 58, 2022

A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions

Abstract

A universal aptamer against spike-proteins of diverse SARS-CoV-2 variants was discovered via DNA SELEX towards the wild-type (WT) spike-protein. This aptamer, A1C1, binds to the WT spike-protein or other variants of concern such as Delta and Omicron with low nanomolar affinities. A1C1 inhibited the interaction between hACE2 and various spike-proteins by 85–89%. This universal A1C1 aptamer can be used to design diagnostic and therapeutic molecular tools to target SARS-CoV-2 and its variants.

Graphical abstract: A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions

Supplementary files

Article information

Article type
Communication
Submitted
10 May 2022
Accepted
17 Jun 2022
First published
24 Jun 2022

Chem. Commun., 2022,58, 8049-8052

Author version available

A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions

A. P. Silwal, R. Jahan, S. K. S. Thennakoon, S. P. Arya, R. M. Postema, E. C. Vander Ark and X. Tan, Chem. Commun., 2022, 58, 8049 DOI: 10.1039/D2CC02647C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements